<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00336011</url>
  </required_header>
  <id_info>
    <org_study_id>186/02</org_study_id>
    <nct_id>NCT00336011</nct_id>
  </id_info>
  <brief_title>Safety of Cardiac Pacemakers in 1.5T Tesla MRI</brief_title>
  <official_title>Studie Zur Sicherheit Von Medtronic Schrittmachern Bei Magnetresonanz-Bildgebungsverfahren an 1,5 Tesla-Systemen Study to Evaluate Safety Medtronic Pacemakers in MR Imaging at 1.5T Tesla)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <brief_summary>
    <textblock>
      To evaluate short-term and long-term effects by MR imaging on the technical and functional&#xD;
      status of Medtronic pacemakers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The presence of a cardiac pacemaker (PM) is currently considered an absolute contraindication&#xD;
      to MR imaging, and most patients with PM are excluded from having MRI. In 2002 there were&#xD;
      approximately 2.4 million patients in the US with cardiac PM, and this number is growing by&#xD;
      80,000 annually. A previous study has shown that MRI is indicated in 17% of all patients with&#xD;
      pacemakers within 12 months of device placement 1, demonstrating the need for a practical and&#xD;
      safe approach for performing MRI on PM patients.&#xD;
&#xD;
      The aim of this study is to develop a strategy for safe performance of MR imaging at 1.5T,&#xD;
      which included exclusion of pacemaker dependent patients and those requiring imaging of the&#xD;
      thorax, restriction of specific absorption rate (SAR) values to minimize the risk of lead&#xD;
      heating, and PM reprogramming to avoid interference from time varying gradient fields. The&#xD;
      safety of this approach is then evaluated in a large group of PM patients including&#xD;
      assessment of potential myocardial thermal injury by measuring serum troponin I and pacing&#xD;
      capture thresholds, and performing a 3-month follow-up to evaluate long-term effects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2002</start_date>
  <completion_date>January 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment>75</enrollment>
  <condition>Heart Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic resonance imaging</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Urgent need for an MRI examination&#xD;
&#xD;
          -  Presence of a Medtronic PM system manufactured between 1993 and 2004&#xD;
&#xD;
          -  Stable pacemaker physical parameters&#xD;
&#xD;
               -  Battery voltage &gt; 2.7 V&#xD;
&#xD;
               -  Battery impedance &lt; 2000 Ohm&#xD;
&#xD;
               -  Battery estimated remaining lifetime &gt; 6 months&#xD;
&#xD;
               -  Lead impedances 200-2000 Ohm&#xD;
&#xD;
          -  Stable pacing parameters&#xD;
&#xD;
               -  Pacing capture threshold &lt;2.5V at a pulse duration of 0.4ms&#xD;
&#xD;
               -  Sensing &gt; 5mV&#xD;
&#xD;
          -  Minimum 3 months since pacemaker and lead implantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  PM system manufacturer other than Medtronic&#xD;
&#xD;
          -  History of ventricular tachycardia (VT) or ventricular fibrillation&#xD;
&#xD;
          -  Unstable angina&#xD;
&#xD;
          -  Myocardial infarction within the previous 3 months&#xD;
&#xD;
          -  Cardiothoracic surgery within the previous 3 months&#xD;
&#xD;
          -  Complete atrioventricular block&#xD;
&#xD;
          -  Absolute pacemaker dependence&#xD;
&#xD;
               -  Heart rate &lt; 40 bpm or&#xD;
&#xD;
               -  Heart rate &lt; 60 bpm producing neurological symptoms&#xD;
&#xD;
          -  Presence of an abdominal pacemaker with lead length &gt; 70 cm&#xD;
&#xD;
          -  Presence of MRI incompatible bioimplants or other MRI incompatible materials&#xD;
&#xD;
          -  Request for an MR examination of the chest, including the heart, breasts and thoracic&#xD;
             spine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torsten Sommer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bonn, Department of Radiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Bonn, Department of Radiology</name>
      <address>
        <city>Bonn</city>
        <state>NRW</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2006</verification_date>
  <study_first_submitted>June 9, 2006</study_first_submitted>
  <study_first_submitted_qc>June 9, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2006</study_first_posted>
  <last_update_submitted>June 9, 2006</last_update_submitted>
  <last_update_submitted_qc>June 9, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 12, 2006</last_update_posted>
  <keyword>pacemaker</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

